Monday, October 3, 2022


Biotechnology News Magazine

KSL Biomedical, Inc. Announces Expansion to Canada with Acquisition of Pulse Scientific

U.S. based developer of diagnostic & therapeutics establishes KSL Biomedical Canada, Inc., seeks to actively build a leadership team to expand from the Greater Toronto Area throughout Canada

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

KSL Biomedical, Inc., developers of novel diagnostic and therapeutic applications for immunology, oncology, virology, and genomics, announces expansion into Canada with the acquisition of Pulse Scientific, Inc. a diagnostic product’s manufacturer and distributor of medical, laboratory, and research products located in Toronto.

With the incorporation of KSL Biomedical Canada, Inc., and the acquisition of Pulse Scientific, KSL extends its international base for product distribution and laboratory sales, positioning the company to merge additional technology, business lines, and acquisition targets in Burlington, the Greater Toronto Area (GTA), and beyond.

Pulse Scientific specializes in the manufacturing and distribution of technical microbiology products and controls for clinical, industrial, and pharma customers, as well as in vitro diagnostic (IVD) tests for laboratories and physicians.  The company is ISO 13485 certified and licensed by Health Canada, positioning it to distribute medical devices and in-vitro diagnostics in Canada, Europe, and many other markets throughout the world.

“Our leadership team brings to Canada decades of scientific training and experience in diagnostics and deep relationships with market leaders who can assist in identifying emerging industry opportunities and introducing novel applications to address them. We expect the acquisition to invigorate access to markets for existing Pulse Scientific and KSL Biomedical products, as well as complementary products to be identified by our incoming Canadian business development team,” said Kevin Lawson, President, and CEO of KSL Biomedical.

Presenting a number of synergistic opportunities, the acquisition allows KSL to add proprietary products and services to its pipeline, including exclusive diagnostics, laboratory products, medical devices, and assays, utilizing proprietary biomarkers and instrumentation.

“It is an exciting opportunity for Pulse Scientific to be part of a vibrant and forward-thinking organization like KSL. The clear business vision and strategy planning, coupled with strong business ethics among the principals will bring continual success to their corporation. I personally will be able to contribute to sales and marketing efforts with rewarding experiences,” said Allen Chan, President of Pulse Scientific.

As a regulatory agent and contract research organization (CRO), KSL is well-positioned to secure Health Canada clearance for manufacturers outside of Canada seeking access to the Canadian market and Canadian companies seeking regulatory clearances in large markets outside of Canada.

With the establishment of KSL Biomedical Canada, the company is now looking to build a strong, dynamic leadership team to run the new division. “We are always looking to grow KSL whether through innovation spearheaded by our various diagnostic teams or from outside the company; we are open to collaborative business opportunities,” added Lawson.“We’re also recruiting professionals who can accelerate our growth, including leaders for our Canada unit. Specifically, we expect to hire a number of positions in business development, sales, and R&D.”

Pulse Scientific is located on the shores of Lake Ontario between Toronto and Niagara Falls in Burlington, Ontario. For those interested in working with an innovative, growing biomedical organization, send a resume to

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine